Atlas Trials

Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD

Clinical trial NCT00278200 · TERMINATED

Trial details

NCT number
NCT00278200
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoproliferative Disorder
Start date
2003-01-01
Primary completion
2012-08-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.